Skip to content

Dendritic Cells-Derived Exosomes in Human Sepsis

A Cohort Study to Investigate the Impacts of Peripheral Blood Dendritic Cells-Derived Exosomes at Early Phase on the Prognosis in Human Sepsis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02957279
Enrollment
50
Registered
2016-11-07
Start date
2016-11-30
Completion date
2017-10-31
Last updated
2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

sepsis, exosomes, dendritic cell

Brief summary

The amount of peripheral blood exosomes has been confirmed to change in the endotoxin-induced infection. The primary objectives of this study are to compare the changes of peripheral blood dendritic cell-derived exosomes in the patients with sepsis and the healthy controls.

Detailed description

This is a prospective, single-centered, clinical cohort study.

Interventions

DRUGAntibiotics

In the sepsis group, antibiotics were used when needed.

Sponsors

Jinling Hospital, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients were selected with the diagnostic standard Sepsis 3.0. * Healthy volunteers do not have serious illness.

Exclusion criteria

* Patients or volunteers do not agree to provide written informed consent and / or can not be legally authorized to provide informed consent. * Patients give up treatments. * Patients or volunteers withdrew from the study.

Design outcomes

Primary

MeasureTime frame
Amount of dendritic cell-derived exosomesThe first 4 hour after admission

Secondary

MeasureTime frame
Compositions of microRNA in the dendritic cell-derived exosomesThe first 4 hour after admission

Countries

China

Contacts

Primary ContactJianan Ren, MD
jiananr@gmail.com862580860108
Backup ContactYuan Li, MD
liyuan9006@gmail.com8615751866716

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026